URINALYSIS MARKET ANALYSIS

Leading Companies

Global Urinalysis Market: Key Developments

In July 2022, Arkray announced the launch of AUTION AI-4510, an innovative automated urine sediment analyzer with built-in capabilities to speed up operations and with on-board auto dilution that eliminates waste and ensures greater accuracy. 

In June 2022, Mylab Discovery Solutions launched PregaScreen, an at-home pregnancy test kit that allows women to detect their pregnancy status themselves. With the launch of this test kit, the company marks its foray into the female healthcare segment.

In October 2021, Inpeco and Sysmex Europe launched the next game-changer in urinalysis. The collaboration between Sysmex and Inpeco takes advantage of the Sysmex’s UN-Series urinalysis solutions and Inpeco’s FlexLab TM track, together making the next step towards a fully automated urinalysis workflow solution of the highest level.

In September 2021, Beckman Coulter launched a urinalysis analyzer, DxU Iris Workcell, a fully automated system that streamlines urinalysis workflow and reduces manual reviews to 4%.

Global Urinalysis Market: Key Companies Insights

The global urinalysis market is highly competitive. This is attributed to the rise in burden of CKD (chronic kidney disease) and growing geriatric population, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global urinalysis market are Arkray Inc., Abbott Laboratories, Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers AG, Cardinal Health Inc., Acon Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, and Danaher Corporation (Beckman Coulter Inc.), among others.